Health ❯ Healthcare ❯ Clinical Research

Clinical Trials

Phase 3 Studies Phase 3 Trials Efficacy Studies Randomized Controlled Trials Real-World Evidence Patient Outcomes Phase 2 Trials Phase III Trials Patient Care Phase II Trials

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

The Nature Medicine analysis suggests genetic testing could let doctors prevent heart failure in high-risk patients before symptoms appear.

Maternal RSV Vaccine Cuts Infant Hospitalizations by About 70%

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

FDA Approves Decnupaz for Rare Blood Cancer

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

Grenoble Team Tests Europe’s First Tumor-Implant Radiotherapy for Pancreatic Cancer

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Tempus AI and USC Launch Collaboration to Integrate AI in Precision Medicine

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

EMA Panel Recommends Redemplo for Familial Chylomicronaemia Syndrome

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

Opus and Viatris Present Phase 3 Phentolamine Data at ASCRS 2026

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1